New biologic option shown to reduce exacerbations and extend time to first flare More: MHRA approves Nucala for eosinophilic COPD in adults on triple therapy Source: News
read more
Sublingual apomorphine film offers rapid relief for OFF episodes More: Bial launches new sublingual Parkinson’s treatment in UK Source: News
read moreThough Gilead Sciences made waves last June with a landmark FDA approval for its twice-yearly HIV preventative Yeztugo (lenacapavir), the first-in-class drug had previously been used as a long-acting treatment for the viral infection. Now, Gilead has conducted an analysis
read moreViking Therapeutics and Aspen Neuroscience have both stepped up their commercialization planning, each tapping leaders with resumes spanning the likes of Amgen, Eli Lilly, Merck and GSK to oversee launch preparations for their obesity and Parkinson’s hopefuls. More: Viking enlists
read moreUnder the agreement, Genesis is responsible for marketing Daiichi’s 2023-approved acute myeloid leukemia med Vanflyta in 13 European countries. More: Daiichi taps Genesis to handle commercialization of leukemia med Vanflyta in 13 European countries Source: fierce
read moreThe FDA is apparently not charmed by the mischievous “Lipid Lurkers” in an Esperion Therapeutics commercial for cholesterol-lowering drug Nexlizet. More: FDA untitled letter skewers Esperion’s claims about cholesterol med Nexlizet in TV ad Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals